Market Cap 148.61M
Revenue (ttm) 31.02M
Net Income (ttm) -57.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -186.46%
Debt to Equity Ratio 0.00
Volume 63,900
Avg Vol 197,610
Day's Range N/A - N/A
Shares Out 100.41M
Stochastic %K 16%
Beta 1.49
Analysts Strong Sell
Price Target $10.00

Latest News on ACIU

Alzheimer's vaccine licensing deal boosts AC Immune

May 13, 2024, 8:47 AM EDT - 1 year ago

Alzheimer's vaccine licensing deal boosts AC Immune


AC Immune Announces Upcoming Presentations at AD/PD™ 2024

Feb 22, 2024, 7:00 AM EST - 1 year ago

AC Immune Announces Upcoming Presentations at AD/PD™ 2024


AC Immune SA Appoints New Chief Medical Officer

Jul 26, 2023, 7:00 AM EDT - 1 year ago

AC Immune SA Appoints New Chief Medical Officer


AC Immune Holds Annual General Meeting of Shareholders

Jun 23, 2023, 4:30 PM EDT - 1 year ago

AC Immune Holds Annual General Meeting of Shareholders